The latest in research and treatment for Parkinson's disease

In recent weeks, some people with Parkinson's disease have gained access to a new treatment that uses technology to monitor signs of the disease. The FDA approved the treatment, called adaptive brain stimulation. According to the University of California San Francisco, the treatment uses an implanted device to continually monitor the brain for symptoms of Parkinson's and then delivers electric pulses to keep those symptoms in check. It's one among several recent advancements geared at helping patients. In New York, a new statewide patient registry supports research into finding a cure. This hour, our guests discuss the latest in Parkinson's disease research and treatment and how to best support patients and caregivers. In studio:

•Yvonne Hylton, co-founder, director, and webmistress of the Rochester Parkinson Network
•Ruth Schneider, M.D., associate professor on the Department of Neurology, Movement Disorders and the Center for Health and Technology at the University of Rochester Medical Center

0:00 Introduction
2:25 New adaptive brain stimulation technology
3:05 How deep brain stimulation works
4:26 Who can get brain stimulation?
8:14 Living with Parkinson’s and DBS
9:10 Traditional vs. Adaptive DBS
11:08 Inside a DBS surgery
13:51 How DBS boosts life quality
18:18 A personal Parkinson’s diagnosis
25:38 Daily struggles with Parkinson’s
30:02 Pesticides and Parkinson’s risk
36:14 Latest FDA-approved treatments
40:03 Fears over research and EPA cuts
46:50 Talking openly about Parkinson’s
50:06 New respite care grants unveiled

__________________________

For more shows and information head to https://www.wxxinews.org/show/connect....

Be part of the program with questions or comments by phone at 844-295-TALK (8255), emailing [email protected] or using the chat on the live stream.

Do you have a story that needs to be shared? https://www.wxxinews.org/pitch-your-s...
__________________________

Become a member of WXXI: https://www.wxxi.org/donate

Never miss a headline with our daily newsletter: https://www.wxxinews.org/newsletter.